Carbon and nitrogen limitation increase chitosan antifungal activity in Neurospora crassa and fungal human pathogens

Fungal Biology

Volumn 119, Issue 2-3, 2015, Pages 154-169

  Lopez Moya, Federico ^a   Colom Valiente, Maria F ^b   Martinez Peinado, Pascual ^a   Martinez Lopez, Jesus E ^c   Puelles, Eduardo ^c   Sempere Ortells, Jose M ^a   Lopez Llorca, Luis V ^a  

^a UNIVERSITY OF ALICANTE   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^c INSTITUTO DE NEUROCIENCIAS   (Spain)

Author keywords

Candida spp.; Fusarium proliferatum; Mammalian cell lines; Membrane permeabilization; Nutrient limitation; ROS

Indexed keywords

CHITIN; FUNGAL DISEASE; GERM CELL; GLUCOSE; IDENTIFICATION KEY; PATHOGEN; PERMEABILITY; SURVIVORSHIP;

CANDIDA; CANDIDA ALBICANS; FUNGI; FUSARIUM PROLIFERATUM; GALLERIA MELLONELLA; MAMMALIA; NEUROSPORA CRASSA;

ANTIFUNGAL AGENT; CARBON; CHITOSAN; CULTURE MEDIUM; GLUCOSE; LACTIC ACID DERIVATIVE; NITROGEN; REACTIVE OXYGEN METABOLITE;

ANIMAL; CANDIDA; CELL MEMBRANE; CELL SURVIVAL; CHEMISTRY; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; CULTURE MEDIUM; DRUG EFFECTS; EPITHELIUM CELL; FILOBASIDIELLA; FUSARIUM; HEK293 CELL LINE; HUMAN; METABOLISM; MICROBIAL VIABILITY; NEUROSPORA CRASSA; PERMEABILITY; PHYSIOLOGY;

ANIMALS; ANTIFUNGAL AGENTS; CANDIDA; CARBON; CELL MEMBRANE; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; CHITOSAN; COS CELLS; CRYPTOCOCCUS; CULTURE MEDIA; EPITHELIAL CELLS; FUSARIUM; GLUCOSE; HEK293 CELLS; HUMANS; LACTATES; MICROBIAL VIABILITY; NEUROSPORA CRASSA; NITROGEN; PERMEABILITY; REACTIVE OXYGEN SPECIES;

EID: 84924167928     PISSN: 18786146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.funbio.2014.12.003     Document Type: Article

References (47)

1. Aguirre J., Ríos-Momberg M., Hewitt D., Hansberg W. Reactive oxygen species and development in microbial eukaryotes. Trends in Microbiology 2005, 13(3):111-118.
2. Allan C.R., Hadwiger L.A. The fungicidal effect of chitosan on fungi of varying cell wall composition. Experimental Mycology 1979, 3:285-287.
3. Baker L.G., Specht C.A., Donlin M.J., Lodge J.K. Chitosan, the deacetylated for of the chitin, is necessary for cell wall integrity in Cryptococcus neoformans. Eukaryotic Cell 2007, 6(5):855-867.
4. Baker L.G., Specht C.A., Lodge J.K. Cell wall chitosan is necessary for virulence in the opportunistic pathogen Cryptococcus neoformans. Eukaryotic Cell 2011, 10(9):1264-1268.
5. Borges O., Borchard G., de Sousa A., Junginger H.E., Cordeiro-da-Silva A. Induction of lymphocytes activated marker CD69 following exposure to chitosan and alginate biopolymers. International Journal of Pharmaceutics 2007, 337(1-2):254-264.
6. Burke D. Methods in Yeast Genetics: a Cold Spring Harbor Laboratory course manual 2000, Cold Spring Harbor Laboratory, Plainview, N.Y.
7. Calamari S., Bojanich M., Barembaum S., Berdicevski N., Azcurra A. Antifungal and post-antifungal effects of chlorhexidine, fluconazole, chitosan and its combinations on Candida albicans. Medicina Oral Patologia Oral Cirugia Bucal 2011, 16(1):e23-e28.
8. Carneiro P., Duarte M., Videira A. Disruption of alternative NAD(P)H dehydrogenases leads to decreased mitochondrial ROS in Neurospora crassa. Free Radical Biology & Medicine 2012, 52(2):402-409.
9. Castro A., Lemos C., Falcão A., Glass N.L., Videira A. Increased resistance of complex I mutants to phytosphingosine-induced programmed cell death. Journal of Biological Chemistry 2008, 283(28):19314-19321.
10. Chen C., Dickman M.B. Proline suppresses apoptosis in the fungal pathogen Colletotrichum trifolii. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(9):3459-3464.
11. Clinical and Laboratory Standards Institute Reference method for broth dilution antifungals susceptibility testing of filamentous fungi; approved standards 2008, CLSI Document M38-A2. Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute, Wayne, Pa. 2nd edn.
12. Cowen L.E., Singh S.D., Köhler J.R., Collins C., Zaas A.K., Schell W.A., Aziz H., Mylonakis E., Perfect J.R., Whitesell L., Lindquist S. Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(8):2818-2823.
13. Ene I.V., Adya A.K., Wehmeier S., Brand A.C., Maccallum D.M., Gow N.A.R., Brown A.J.P. Host carbon sources modulate cell wall architecture, drug resistance and virulence in a fungal pathogen. Cellular Microbiology 2012, 14(9):1319-1335.
14. Ene I.V., Heilmann C.J., Sorgo A.G., Walker L.A., De Koster C.G., Munro C.A., Klis F.M., Brown A.J.P. Carbon source-induced reprogramming of the cell wall proteome and secretome modulates the adherence and drug resistance of the fungal pathogen Candida albicans. Proteomics 2012, 12(21):3164-3179.
15. Fuchs B.B., O'Brien E., Khoury J.B.E., Mylonakis E. Methods for using Galleria mellonella as a model host to study fungal pathogenesis. Virulence 2010, 1(6):475-482.
16. Hongo T., Fujii Y., Igarashi Y. An invitro chemosensitivity test for the screening of anti-cancer drugs in childhood leukemia. Cancer 1990, 65(6):1263-1272.
17. Howlett N.G., Avery S.V. Induction of lipid peroxidation during heavy metal stress in Saccharomyces cerevisiae and influence on plasma membrane fatty acid unsaturation. Applied and Environmental Microbiology 1997, 63(8):2971-2976.
18. Jaime M.D.L.A., Lopez-Llorca L.V., Conesa A., Lee A.Y., Proctor M., Heisler L.E., Gebbia M., Giaever G., Westwood J.T., Nislow C. Identification of yeast genes that confer resistance to chitosan oligosaccharide (COS) using chemogenomics. BMC Genomics 2012, 13(1):267.
19. Kaushik N.K., Kim H.S., Chae Y.J., Lee Y.N., Kwon G., Choi E.H., Kim I.T. Synthesis and anticancer activity of di (3-thienyl) methanol and di (3-thienyl) methane. Molecules 2012, 17(10):11456-11468.
20. Kowaltowski A.J., de Souza-Pinto N.C., Castilho R.F., Vercesi A.E. Mitochondria and reactive oxygen species. Free Radical Biology & Medicine 2009, 47:333-343.
21. Kulikov S.N., Lisovskaya S.A., Zelenikhin P.V., Bezrodnykh E.A., Shakirova D.R., Blagodatskikh I.V., Tikhonov V.E. Antifungal activity of oligochitosans (short chain chitosans) against some candida species and clinical isolates of Candida albicans: molecular weight-activity relationship. European Journal of Medicinal Chemistry 2014, 74:169-178.
22. Kumar R.M.N.V. A review of chitin and chitosan applications. Reactive and Functional Polymers 2000, 46(1):1-27.
23. Lorenz M.C., Fink G.R. The glyoxylate cycle is required for fungal virulence. Nature 2001, 412(6842):83-86.
24. Lyons A.B. Analysing cell division invivo and invitro using flow cytometric measurement of CFSE dye dilution. Journal of Immunological Methods 2000, 243(1-2):147-154.
25. Martin-Bland J., Altman D.G. Survival probabilities (the Kaplan-Meier method). British Medical Journal 1998, 317(7172):1572.
26. Mesa-Arango A.C., Forastiero A., Bernal-Martínez L., Cuenca-Estrella M., Mellado E., Zaragoza O. The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast. Medical Mycology 2013, 51(5):461-472.
27. Miceli M.H., Díaz J.A., Lee S.A. Emerging opportunistic yeast infections. Lancet Infectious Diseases 2011, 11(2):142-151.
28. Mittler R. Oxidative stress, antioxidants and stress tolerance. Trends in Plant Science 2002, 7(9):405-410.
29. Mittler R., Vanderauwera S., Suzuki N., Miller G., Tognetti V.B., Vandepoele K., Gollery M., Shulaev V., Van Breusegem F. ROS signaling: the new wave?. Trends in Plant Science 2011, 16(6):300-309.
30. Nitsche B.M., Jørgensen T.R., Akeroyd M., Meyer V., Ram A.F.J. The carbon starvation response of Aspergillus niger during submerged cultivation: insights from the transcriptome and secretome. BMC Genomics 2012, 13(1):380.
31. Palma-Guerrero J., Jansson H.-B., Salinas J., Lopez-Llorca L.V. Effect of chitosan on hyphal growth and spore germination of plant pathogenic and biocontrol fungi. Journal of Applied Microbiology 2008, 104(2):541-553.
32. Palma-Guerrero J., Huang I.C., Jansson H.-B., Salinas J., Lopez-Llorca L.V., Read N.D. Chitosan permeabilizes the plasma membrane and kills cells of Neurospora crassa in an energy dependent manner. Fungal Genetics and Biology 2009, 46:585-594.
33. Palma-Guerrero J., Lopez-Jimenez J.A., Pérez-Berná A.J., Huang I., Jansson H., Salinas J., Lopez-Llorca L.V. Membrane fluidity determines sensitivity of filamentous fungi to chitosan. Molecular Microbiology 2010, 75(4):1021-1032.
34. Peña A., Sánchez N.S., Calahorra M. Effects of chitosan on Candida albicans: conditions for its antifungal activity. BioMed Research International 2013, 2013(2013). Article ID 527549, 15. http://dx.doi.org/10.1155/2013/527549.
35. Prigneau O., Porta A., Poudrier J.A., Colonna-Romano S., Noël T., Maresca B. Genes involve in β-oxidation, energy metabolism and glyoxylate cycle are induced by Candida albicans during macrophage infection. Yeast 2003, 20(8):723-730.
36. Qi L., Xu Z., Jiang X., Li Y., Wang M. Cytotoxic activities of chitosan nanoparticles and copper-loaded nanoparticles. Bioorganic & Medicinal Chemistry Letters 2005, 15(5):1397-1399.
37. Ramírez M.A., Lorenz M.C. Mutations in alternative carbon utilization pathways in Candida albicans attenuate virulence and confer pleiotropic phenotypes. Eukaryotic Cell 2007, 6(2):280-290.
38. Richardson M., Lass-Flörl C. Changing epidemiology of systemic fungal infections. Clinical Microbiology and Infection 2008, 14(4):5-24.
39. Shapiro R.S., Robbins N., Cowen L.E. Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiology and Molecular Biology Reviews 2011, 75(2):213-267.
40. Summerbell R.C., Richardson S.E., Kane J. Fusarium proliferatum as an agent of disseminated infection in an immunosuppressed patient. Journal of Clinical Microbiology 1988, 26(1):82-87.
41. Szilágyi M., Miskei M., Karányi Z., Lenkey B., Pócsi I., Emri T. Transcriptome changes initiated by carbon starvation in Aspergillus nidulans. Microbiology (UK) 2013, 159(1):176-190.
42. Thevissen K., Terras F.R., Broekaert W.F. Permeabilization of fungal membranes by plant defensins inhibits fungal growth. Applied and Environmental Microbiology 1999, 65:5451-5458.
43. Vogel H.J. A convenient growth medium for Neurospora. Microbial Genetics Bulletin 1956, 13:42-46.
44. Yan Y., Wei C., Zhang W., Cheng H., Liu J. Cross-talk between calcium and reactive oxygen species signaling. Acta Pharmacologica Sinica 2006, 27(7):821-826.
45. Yari S., Parivar K., Nabiuni M., Keramatipour M. Effect of embryonic cerebrospinal fluid on proliferation and differentiation of neuroprogenitor cells. Cell Journal 2013, 15(1):29-36.
46. Younes I., Sellimi S., Rinaudo M., Jellouli K., Nasri M. Influence of acetylation degree and molecular weight of homogeneous chitosans on antibacterial and antifungal activities. International Journal of Food Microbiology 2014, 185:57-63.
47. Zakrzewska A., Boorsma A., Brul S., Hellingwerf K.J., Klis F.M. Transcriptional response of Saccharomyces cerevisiae to the plasma membrane-perturbing compound chitosan. Eukaryotic Cell 2005, 4:703-715.